|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
In this video, learn what the formulation and parameter targets are to optimize direct compression formulations, and how to accelerate development with BASF’s new all-in-one fit-for-purpose tableting solution.
|
|
 |
|
As an embedded CMO, we leverage decades of scientific expertise, operational excellence, and best-in-class facilities to provide you with….
|
|
 |
|
In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..
|
|
 |
|
For new drug products, it is essential that pharmaceutical companies utilize the experience of container suppliers as early as possible.
|
|
|
|
|
|
|
|
|
Vanessa Zann, PhD, presents the opportunities and challenges when transitioning from an IR to MR formulation, and reviews the therapeutic benefits and challenges associated with MR formulations, GI physiology environments and API physicochemical properties, technology choices, and how drug developers can achieve translation success.
|
|
|
Andreas Eschbach says a people-centered approach to digitizing manufacturing operations helps ensure the success of any digitalization initiative. But in pharmaceutical manufacturing, having insights into each area of operation is critical to production quality and compliance.
|
|
|
Gael Touya, President of Aptar Pharma, and Sai Shankar, President, M&A, Strategy, BD, Marketing, Drug Services, Aptar Pharma, discuss the burgeoning potential in the future of pharma and digital health, how the company is a strategic partner to key players in these spaces, and the investments Aptar is making to support the growing demand.
|
|
|
James A. Roszell, PhD, and Doreen McMorran demonstrate how this technology has demonstrated potential in the transdermal administration of glucagon-like peptide-1 (GLP-1) agonists and cannabinoid receptor type 1 (CB-1) antagonists, primarily targeting obesity management and other conditions requiring glucose regulation.
|
|
|
Matthias Knarr, PhD, and True Rogers, PhD, review the latest insights behind CR formulations using HPMC excipients and how HPMC substitution specifically can assist formulators in developing cutting-edge CR delivery systems with differentiated performance.
|
|
|
|
|
|
|
|
|

Halo Pharma is a leading provider of pharmaceutical services, including contract dosage form development, commercial manufacturing and analytical services. Our capabilities in the areas of tech transfer, process and pharmaceutical product development, formulation development, production, scale-up and validation, and analytical method development allow us to partner with clients from development through commercialization or at any point along the way. Our expertise across many dosage forms, including complex oral solids, topicals, oral solutions and suspensions and the manufacture of controlled substances is unmatched in North America. Halo Pharma serves a growing global customer base across multiple regulatory environments. These attributes allow Halo Pharma to be a partner of choice for many of today’s large pharma, generic pharma and biotech pharma companies. Click here for more.
|
|
|
|
|
|
 |
|
In this video, the Lubrizol team together with the IMCD US team takes you through formulation aspects of Carbopol® polymers as well as the results of a case study on an Acetaminophen oral suspension formulation.
|
|
 |
|
ABITEC Technical Business Director, John Tillotson, RPh, PhD, discusses ABITEC’s latest products: The ABISOL Emulsion Preconcentrate kit for the easy formulation of emulsified drug delivery systems and the….
|
|
|
|
|
|
|
|
 |
|
Mucoadhesion Matters
And so does your choice of mucoadhesive polymer.
This technical brief will cover the use of polymers in a variety of dosage forms (buccal/sublingual tablets, liquid, semi-solid formulations, and oral care products) to impart mucoadhesion. The basic mechanism …
|
|
 |
|
When a mid-sized pharmaceutical company asked Adare to make a version of their drug that was more convenient for patients with tremors or swallowing difficulties, our experts created a sprinkle formulation of the drug. In this CPHI Award-winning case study, …
|
|
 |
|
CDMOs are emerging as critical drivers of innovation within the pharmaceutical and biotech industries. As the pharmaceutical industry continues to evolve, we can expect to see CDMOs play an increasingly important role in drug development and manufacturing. Many companies within …
|
|
|
|
|
Upcoming eNewsletter Features:
January 22 – Drug Delivery
January 29 – Bioavailability
|
|
|
|
|
|
|
|